BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $256,594 | -61.7% | 6,799 | -53.8% | 0.00% | -66.7% |
Q2 2023 | $670,005 | +45.1% | 14,706 | +29.2% | 0.00% | +50.0% |
Q1 2023 | $461,735 | +6.2% | 11,384 | +33.5% | 0.00% | 0.0% |
Q4 2022 | $434,723 | -86.2% | 8,529 | -85.4% | 0.00% | -88.2% |
Q3 2022 | $3,151,000 | -18.7% | 58,496 | -3.0% | 0.02% | -10.5% |
Q2 2022 | $3,874,000 | +22.2% | 60,314 | +47.6% | 0.02% | +35.7% |
Q1 2022 | $3,169,000 | -28.0% | 40,863 | -20.3% | 0.01% | -26.3% |
Q4 2021 | $4,400,000 | +33.2% | 51,263 | +24.8% | 0.02% | +26.7% |
Q3 2021 | $3,304,000 | +59.5% | 41,074 | +59.6% | 0.02% | +50.0% |
Q2 2021 | $2,072,000 | +47.1% | 25,739 | +54.1% | 0.01% | +25.0% |
Q1 2021 | $1,409,000 | +15.3% | 16,704 | +9.7% | 0.01% | +14.3% |
Q4 2020 | $1,222,000 | +4.4% | 15,227 | +4.7% | 0.01% | -12.5% |
Q3 2020 | $1,170,000 | -3.5% | 14,549 | +3.4% | 0.01% | -11.1% |
Q2 2020 | $1,212,000 | +2.0% | 14,075 | -3.8% | 0.01% | -18.2% |
Q1 2020 | $1,188,000 | -14.1% | 14,634 | -11.5% | 0.01% | +10.0% |
Q4 2019 | $1,383,000 | +17.0% | 16,535 | +22.4% | 0.01% | 0.0% |
Q3 2019 | $1,182,000 | +7.6% | 13,511 | +0.7% | 0.01% | 0.0% |
Q2 2019 | $1,099,000 | -0.7% | 13,421 | -1.4% | 0.01% | 0.0% |
Q1 2019 | $1,107,000 | +37.2% | 13,614 | +11.0% | 0.01% | +11.1% |
Q4 2018 | $807,000 | – | 12,267 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |